File

Other

The RELID study about radiation related cataracts was the ´Editor Award´ winner of JVIR as the Outstanding Clinical Research Paper for 2013

The development of interventional cardiology has led us to successfully treat injuries and angiographic situations increasingly complex....

solaci - 3 February, 2014

Learn More

Acute coronary syndromes

Decreased bleeding with radial access leaves little to bivalirudin for additional benefit

Original title: Bivalirudin or heparin in primary angioplasty performed through the transradial approach: results from a multicentre registry. Reference: Sciahbasi...

solaci - 31 January, 2014

Learn More

Chronic Ischemic cardiopathy

The FFR changes the treatment strategy in almost half of patients

Original title: Outcome impact of coronary revascularization strategy reclassification with fractional flow reserve at time of diagnostic angiography. Reference: Van...

solaci - 29 January, 2014

Learn More

Chronic Ischemic cardiopathy

Malapposition in drug-eluting stents. Much more common and much less serious than we thought

Original title: Incidences, Predictors, and Clinical Outcomes of Acute and Late Stent Malapposition Detected by Optical Coherence Tomography...

solaci - 28 January, 2014

Learn More

Chronic Ischemic cardiopathy

Ischemic versus anatomical risk. Is anyone better to help us decide therapeutically?

Original title: Predicting Outcome in the COURAGE Trial. Coronary Anatomy Versus Ischemia. Reference: G. B. John Mancini et al. J...

solaci - 24 January, 2014

Learn More

Chronic Ischemic cardiopathy

Everolimus-eluting stent and DEB in restenosis for BMS. Good results of both with some expected differences.

Original title: A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent In-Stent Restenosis:...

solaci - 22 January, 2014

Learn More

Chronic Ischemic cardiopathy

Longer follow-up registry of angioplasty in left main coronary artery. Significant differences according to the diseased segment.

Original title: The DELTA Registry (Drug-Eluting Stent for Left Main Coronary Artery Disease): A Multicenter registry Evaluating Percutaneous...

solaci - 20 January, 2014

Learn More

Antithrombotic Anticoagulants

Stent reestenosis, the only subgroup that benefits from longer double antiaggregation

Original title: Short vs. Long Term Duration of Dual Antiplatelet Therapy in Patients treated for InstentRestenosis. A PRODIGY...

solaci - 13 December, 2013

Learn More

The RELID study about radiation related cataracts was the ´Editor Award´ winner of JVIR as the Outstanding Clinical Research Paper for 2013

Decreased bleeding with radial access leaves little to bivalirudin for additional benefit

The FFR changes the treatment strategy in almost half of patients

Malapposition in drug-eluting stents. Much more common and much less serious than we thought

Ischemic versus anatomical risk. Is anyone better to help us decide therapeutically?

Everolimus-eluting stent and DEB in restenosis for BMS. Good results of both with some expected differences.

Longer follow-up registry of angioplasty in left main coronary artery. Significant differences according to the diseased segment.

Stent reestenosis, the only subgroup that benefits from longer double antiaggregation

Last News

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Institutional News

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Access